ABCC2 brush‐border expression predicts outcome in papillary renal cell carcinoma: a multi‐institutional study of 254 cases
Open Access
- 7 September 2023
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 83 (6) , 949-958
Abstract
Aims: Papillary renal cell carcinoma (PRCC) histologic subtyping is no longer recommended in the 2022 WHO classification. Currently, WHO/ISUP nucleolar grade is the only accepted prognostic histologic parameter for PRCC. ABCC2, a renal drug transporter, has been shown to significantly predict outcomes in PRCC. In this study we evaluated the prognostic significance of ABCC2 IHC staining patterns in a large, mult-iinstitutional PRCC cohort and assessed the association of these patterns with ABCC2 mRNA expression. Methods and results: We assessed 254 PRCCs for ABCC2 IHC reactivity patterns that were stratified into negative, cytoplasmic, brush-border = 50%. RNA in situ hybridization (ISH) was used to determine the transcript level of each group. Survival analysis was performed with SPSS and GraphPad software. RNA-ISH showed that the ABCC2 group with any brush-border staining was associated with a significant increase in the transcript level, when compared to the negative/cytoplasmic group (P = 0.034). Both ABCC2 groups with brush-border = 50% (P < 0.001) were also associated with worse disease-free survival (DFS) in univariate analysis. Multivariate analysis showed that only ABCC2 IHC brush-border (= 50%) reactivity groups (P = 0.037 and P = 0.003, respectively), and highstage disease (P < 0.001) had a DFS of prognostic significance. In addition, ABCC2 brush-border showed significantly worse DFS in pT1a (P = 0.014), pT1 (P = 0.013), <= 4 cmtumour (P = 0.041) and high stage (P = 0.014) groups, while a similar analysis with high WHO/ISUP grade in these groups was not significant. Conclusion: ABCC2 IHC brush-border expression in PRCC correlates with significantly higher gene expression and also independently predicts survival outcomes.Keywords
Funding Information
- Canadian Urological Association Scholarship Fund
- Ontario Institute for Cancer Research
This publication has 28 references indexed in Scilit:
- Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular AnalysisAmerican Journal of Surgical Pathology, 2017
- Comprehensive Molecular Characterization of Papillary Renal-Cell CarcinomaNew England Journal of Medicine, 2016
- Papillary renal cell carcinoma: correlation of tumor grade and histologic characteristics with clinical outcomeHuman Pathology, 2015
- The Morphologic and Immunohistochemical Spectrum of Papillary Renal Cell CarcinomaAmerican Journal of Surgical Pathology, 2014
- The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic ParametersAmerican Journal of Surgical Pathology, 2013
- Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre studyEuropean Journal of Cancer, 2012
- RNAscopeThe Journal of Molecular Diagnostics, 2012
- The apical conjugate efflux pump ABCC2 (MRP2)Pflügers Archiv - European Journal of Physiology, 2006
- Structure and function of the MRP2 (ABCC2) protein and its role in drug dispositionExpert Opinion on Drug Metabolism & Toxicology, 2006
- Morphologic typing of papillary renal cell carcinoma: Comparison of growth kinetics and patient survival in 66 casesHuman Pathology, 2001